A new European initiative aims to accelerate earlier diagnosis and improve access to treatment for people living with ...

Cardiovascular diseases remain the leading cause of death in Europe, claiming 1.7 million lives annually, the head of the ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), today announced its participation as a key industry partner in ACCESS-AD, a major new European initiative designed to accelerate ...

Developed by a consortium of 30 public and private partners, ACCESS-AD (“Advancing Clinical Care and Equity through Scalable ...

Mosquito-borne diseases such as West Nile virus (WNV), chikungunya, and dengue are spreading more widely and for longer durations across Europe, with health authorities warning that changing climate ...

A network of health security agencies has been established in Europe and Central Asia to bolster the region's preparedness to meet future disease threats. The Pan-European Network for Disease Control ...

Cardiovascular disease remains a major concern in cities, with poor outcomes and high societal cost often driven by unequal access to healthcare.  A pan-European consortium of 34 international ...

In many countries, these trends are going in the wrong direction. Since 2020, antibiotic use has increased in Austria, ...

Europe is grappling with a growing threat from arboviruses—diseases transmitted by mosquitoes, ticks, and sandflies—as infections like dengue, chikungunya, and Zika creep into regions once considered ...

Chronic liver disease and pancreatitis were among the digestive diseases with high increases in incidence and mortality since 2000. Digestive diseases affect more than 300 million people in Europe and ...

At its conference in Bilbao, the European Economic and Social Committee (EESC) urged the European Union to launch a European action plan stepping up cooperation between national health systems. The ...

Expanded leadership bolsters Sciensus' end-to-end model for commercialisation of orphan and specialty medicinal ...